Identification of ACBD3 as a new molecular biomarker in pan-cancers through bioinformatic analysis: a preclinical study

ConclusionAccording to our pan-cancer analysis,ACBD3 may serve as a remarkable prognostic and diagnostic biomarker of pan-cancers as well as contribute to tumor development.ACBD3 may also provide new directions for cancer treatment targets in the future.
Source: European Journal of Medical Research - Category: Research Source Type: research